Paul F. Lizzul
CIK 1711462 · Chief Medical Officer · last filed 2026-05-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.98M
Companies
3
Total Filings
35
Lifetime Open-Market Net
-$745.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TRAX | Chief Medical Officer | 42,669 | $41.85 | $1.79M | $0 | 2 | 2026-05-14 |
| ANAB | Chief Medical Officer | 42,088 | $52.11 | $2.19M | -$895.2K | 20 | 2026-01-09 |
| Sienna Biopharmaceuticals, Inc. (SNNA) Delisted | Chief Medical Officer | 207,045 | — | — | $150.0K | 6 | 2019-08-08 |
Recent Filings · Page 2 of 4
35 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-01-07 | ANAB | Mixed | +10,103 | -$97.9K | EDGAR |
| 2024-09-24 | ANAB | Mixed | — | -$30.3K | EDGAR |
| 2024-09-23 | ANAB | Notice (144) | −1,500 | -$58.0K | EDGAR |
| 2024-09-17 | ANAB | Mixed | +3,780 | -$86.4K | EDGAR |
| 2024-08-16 | ANAB | Mixed | — | -$43.0K | EDGAR |
| 2024-08-14 | ANAB | Notice (144) | −2,000 | -$80.0K | EDGAR |
| 2024-07-24 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2024-07-19 | ANAB | Mixed | — | -$24.8K | EDGAR |
| 2024-07-18 | ANAB | Notice (144) | −1,500 | -$52.5K | EDGAR |
| 2024-01-09 | ANAB | Mixed | +3,591 | -$55.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.